Investment Firm
Overview
Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.
Dec 15, 2019
Series Unknown
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
2
Investor Name |
---|
Nobska Point Capital |
Alopexx |
Cognoptix raised $1300000 on 2019-12-15 in Venture Round
Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.
Company Funding History
10
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jan 10, 2008 | Series A - Cognoptix | - | 849.0K | |
Sep 30, 2014 | Series D - Cognoptix | 3 | - | 15.0M |
Apr 24, 2014 | Debt Financing - Cognoptix | 1 | - | 390.0K |
Jan 07, 2011 | Series C - Cognoptix | - | 4.6M |
Recent Activity
There is no recent news or activity for this profile.